Despite the rapid growth of Korea’s biopharmaceutical market, the government's approval system to support it still relies on ...

ABL Bio has built a new headquarters in Gangnam, Seoul, anchoring its "Vision ABL 2.0."In an interview with Korea Biomedical ...

The mortality rate after acute myocardial infarction (AMI) was found to be higher among self-employed insured individuals ...

AstraZeneca Korea is expanding the therapeutic footprint of its PARP inhibitor Lynparza (ingredient: olaparib) in gynecologic ...

Just two months after German pharma Boehringer Ingelheim secured long-delayed reimbursement for Ofev in Korea, generics are ...

Siemens Healthineers Korea has signed a strategic memorandum of understanding (MOU) with Phantomics, a Korean cardiac imaging ...

Korea’s Vaxcellbio is joining the next wave of cell therapy contenders, backed by a government grant and a platform it says ...

The rift among resigned doctors has been widening since the new government took office.A day after Park Dan, head of the ...

The Ministry of Food and Drug Safety has approved an expanded indication for Vemlidy (ingredient: tenofovir alafenamide), ...

Inventage Lab unveiled its next-generation obesity drug platform technology in a poster presentation at the American Diabetes ...

ABL Bio said Tuesday that its partner I-Mab will present data from the phase 1b study of ABL111 (trademark name: Givastomig) combination therapy in a mini oral presentation at the European Society for ...

Calls are growing to establish a new public medical school in South Jeolla Province, as promised by President Lee Jae ...